Wealth Alliance Sells 205 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Wealth Alliance cut its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 5.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,849 shares of the medical device company’s stock after selling 205 shares during the quarter. Wealth Alliance’s holdings in Cooper Companies were worth $354,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Ashton Thomas Securities LLC acquired a new position in shares of Cooper Companies in the 3rd quarter valued at approximately $25,000. Byrne Asset Management LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at approximately $33,000. Covestor Ltd grew its position in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 200 shares during the period. Brown Brothers Harriman & Co. grew its position in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the period. Finally, West Financial Advisors LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at approximately $49,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.2 %

COO opened at $88.48 on Friday. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The stock’s fifty day simple moving average is $92.94 and its 200 day simple moving average is $99.55. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market cap of $17.66 billion, a PE ratio of 45.37, a price-to-earnings-growth ratio of 2.19 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.87 EPS. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on COO shares. Morgan Stanley decreased their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup reduced their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.